|
|
Article: Paladin And Glide Pharma Sign Exclusive Agreement for Novel Needle- Free Drug Delivery System
- Article from:
- CCNMatthews Newswire
- Article date:
- August 9, 2007
CopyrightCopyright 2007 CCNMatthews Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
MONTREAL, CANADA--(CCNMatthews - Aug. 9, 2007) - Paladin Labs Inc.
(TSX:PLB), a leading Canadian specialty pharmaceutical company, today
announced that it has entered into an exclusive license and
distribution agreement with Glide Pharmaceutical Technologies Limited
(Glide Pharma(TM)) to develop and market Glide Pharma's innovative
Glide SDI(TM) (Solid Dose Injector) needle-free drug delivery
products in Canada. Under the terms of this agreement, Paladin will
assume responsibility for local clinical trials, registration,
marketing, sales and distribution of at least three of Glide Pharma's
pipeline products which include: needle-free versions of sumatriptan,
a leading migraine drug; ...
Related newspaper, magazine, and journal articles:
|
|
Article: SIDEWAYS GLANCE: A new venture.
Money Marketing;
October 16, 2008 ;
700+ words
... ... they have backed include Oxitec, which is pioneering the control of pest insect populations without the use of pesticides, Glide Pharma, a pharmaceutical company enabling fast and simple delivery of drugs, vaccines and solid formulations of the skin, and ...
|
|